Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer

Clinical trial NCT00074867 · COMPLETED

Trial details

NCT number: NCT00074867
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Neoplasms Peritoneal Neoplasms Fallopian Tube Neoplasms

Start date: 2003-10-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.